相关实验视频
Updated: Jan 11, 2026

08:35
In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells
Published on: June 12, 2017
10.7K
SQSTM1/p62 翻译后的修饰和反向过程通过KEAP1-NRF2信号和选择性自来调节疾病的发病
Dongrong Zhu1,2, Yue Li2, Lirong Zhao2
1Department of Molecular Pharmacology, Tianjin Medical University Cancer Institute & Hospital; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, People's Republic of China.
Antioxidants & redox signaling
|November 15, 2025
概括
序列素1 (p62) 通过后翻译性修饰 (PTMs) 调节细胞应激反应和自. 针对这些p62 PTMs为各种疾病提供治疗潜力,包括癌症和神经退行.
科学领域:
- 生物化学和分子生物学
- 细胞生物学 细胞生物学
- 病理学 病理学 病理学
背景情况:
- 序列组1 (SQSTM1/p62) 是一个关键的泛素结合蛋白,参与选择性自和KEAP1-NRF2通路.
- p62作为一个信号枢纽,调节细胞对氧化应激和其他刺激的反应.
- 其活动受到各种后翻译修饰 (PTM) 和它们的反向过程的严格监管.
研究的目的:
- 审查目前对p62的PTM及其反向过程的理解.
- 探索p62 PTMs的功能影响和与疾病相关的机制.
- 确定针对p62 PTMs的治疗策略的新见解.
主要方法:
- 文献综述综合了关于p62 PTMs的当前知识.
- 分析p62 PTMs的功能作用和疾病联系.
- 识别分子调节剂和治疗点.
主要成果:
- p62 PTMs,包括酸化,无化和乙化,在自和KEAP1-NRF2通路中动态调节其功能.
- 对p62 PTMs的失调与癌症,神经退行性疾病和NAFLD等各种病理有关.
- p62 PTM通过直接和间接途径影响疾病机制.
结论:
- p62 PTM是细胞信号传递和恒温的关键调节器.
- 针对p62 PTMs代表了一系列疾病的有希望的治疗途径.
- 对p62 PTM的进一步研究可以导致癌症,神经退行和代谢障碍的新型治疗策略.
相关概念视频
The Proteasome
1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
The Proteasome
10.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.0K
The Unfolded Protein Response
6.2K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
6.2K
Regulation of the Unfolded Protein Response
2.9K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.9K
Covalently Linked Protein Regulators
8.6K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
8.6K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
